J&J's $21B Synthes Buy Gets EU Nod After Divestiture
Johnson & Johnson won approval Thursday in the European Union for the company's $21.3 billion purchase of Swiss orthopedic device maker Synthes Inc., after J&J offered to sell off its worldwide...To view the full article, register now.
Already a subscriber? Click here to view full article